Omdia: Small medium OLED shipment to hit 1 billion units for the first time in 2025GoviEx Uranium (CVE:GXU) Hits New 1-Year Low – Should You Sell?
New Year's eventsBBC Strictly Come Dancing fans issue Chris McCausland and Dianne Buswell complaint over 'words from another planet'
The piece of technology sits unassumingly on top of the helmet of veteran quarterback Sam Darnold during most practices at TCO Performance Center. ADVERTISEMENT It allows the Vikings to capture footage in real time, providing a peek into the past for the man at the forefront of the future. “It’s super cool,” Darnold said. “It’s a really amazing tool to be able to use.” Though the Vikings are very much keeping the focus on this season with big goals in mind, they also have started laying the foundation for next season with the help of a GoPro camera. “This is the first time I’ve done anything like that,” Darnold said. “It doesn’t really feel like anything when it’s on my helmet.” ADVERTISEMENT That’s arguably the biggest part of its appeal. The fact that the GoPro camera weighs much less than a pound means it doesn’t interfere with anything the Vikings are trying to get done on a daily basis. It exists more or less as an accessory for Darnold at this point, taking video from his perspective whether he’s calling a play in the huddle, making a check at the line of scrimmage or scanning the field after the ball is snapped. That has been extremely useful for rookie quarterback J.J. McCarthy as he continues to work his way through his recovery from a knee injury that ended his rookie campaign before it even got started. The ability to see everything through the eyes of Darnold has helped McCarthy train his brain even if he isn’t able to experience it firsthand. ADVERTISEMENT “The mental reps are of utmost importance,” McCarthy said a couple of months ago. “Just watching film from that perspective is really good.” This is the best option for the Vikings right now. Originally, after selecting McCarthy with the No. 10 pick in the 2024 draft, the Vikings hoped he would be able to get live reps himself this season. ADVERTISEMENT Instead, after McCarthy had surgery to repair a torn meniscus, the Vikings are doing everything in their power to make sure he’s ready for next season. That’s something head coach Kevin O’Connell has stressed whenever McCarthy’s name has been brought up. “We wanted to make sure we’re maximizing every moment for him,” O’Connell said. “We thought, ‘How do we make sure we’re doing the things that we need to do to ensure that he’s in the best possible position when he is healthy?'” The use of a GoPro camera is simply another resource the Vikings have at their disposal. ADVERTISEMENT “We’ve done a lot of different stuff that maybe we don’t do with a 10-year veteran quarterback,” O’Connell said. “Just to make sure that we’re farming an ideal learning environment for him to hit the ground running when he’s healthy.” As soon as the GoPro camera captures the footage from a particular practice, McCarthy can go back and watch it, getting a feel for what life is like in the huddle, at the line of scrimmage and after the ball is snapped. Sometimes the Vikings will even put it on in their war room, where there’s a gigantic screen that takes up an entire wall. That grandiose display is something offensive coordinator Wes Phillips appreciates because it makes it feel like McCarthy is inside the helmet. ADVERTISEMENT “It’s pretty cool to watch in there,” Phillips said. “It gives him a chance to see it a little bit more from that perspective.” Some of the other creative ways the Vikings have kept McCarthy on track include allowing him to be a part of the dialogue that goes on between O’Connell and Darnold during games. He was cleared to travel with the team for the first time last month, for example, so he was in attendance at SoFi Stadium when the Vikings suffered a 30-20 loss to the Los Angeles Rams. Just getting a glimpse of what it feels like in the heat of battle will go a long way for McCarthy as he continues to develop. “I’m really excited about having him with us,” O’Connell said. “Any and all areas we can find to maximize those chances, we’re going to use it.” All the while, McCarthy has also been attending meetings, asking questions to O’Connell, Phillips, quarterback coach Josh McCown, assistant quarterbacks coach Grant Udinski and anybody else he can find in their office at TCO Performance Center. “He’s great about saving some questions he has,” Phillips said. “He’ll do that off to the side, understanding that guys are getting ready for the game.” Though the Vikings would’ve loved for McCarthy to be able to learn everything firsthand as a rookie, they are making the most of their current situation, ensuring their young quarterback of the future is completely prepared heading into next season. “Obviously he wants more than anybody to be there physically,” Phillips said. “He’s doing everything he can to be ready when his time comes.” ______________________________________________________ This story was written by one of our partner news agencies. Forum Communications Company uses content from agencies such as Reuters, Kaiser Health News, Tribune News Service and others to provide a wider range of news to our readers. Learn more about the news services FCC uses here .
NEW YORK (AP) — Top-ranked chess player Magnus Carlsen is headed back to the World Blitz Championship on Monday after its governing body agreed to loosen a dress code that got him fined and denied a late-round game in another tournament for refusing to change out of jeans . Lamenting the contretemps, International Chess Federation President Arkady Dvorkovich said in a statement Sunday that he'd let World Blitz Championship tournament officials consider allowing “appropriate jeans” with a jacket, and other “elegant minor deviations” from the dress code. He said Carlsen's stand — which culminated in his quitting the tournament Friday — highlighted a need for more discussion “to ensure that our rules and their application reflect the evolving nature of chess as a global and accessible sport.” Carlsen, meanwhile, said in a video posted Sunday on social media that he would play — and wear jeans — in the World Blitz Championship when it begins Monday. “I think the situation was badly mishandled on their side,” the 34-year-old Norwegian grandmaster said. But he added that he loves playing blitz — a fast-paced form of chess — and wanted fans to be able to watch, and that he was encouraged by his discussions with the federation after Friday's showdown. “I think we sort of all want the same thing,” he suggested in the video on his Take Take Take chess app’s YouTube channel. “We want the players to be comfortable, sure, but also relatively presentable.” The events began when Carlsen wore jeans and a sportcoat Friday to the Rapid World Championship, which is separate from but held in conjunction with the blitz event. The chess federation said Friday that longstanding rules prohibit jeans at those tournaments, and players are lodged nearby to make sartorial switch-ups easy if needed. An official fined Carlsen $200 and asked him to change pants, but he refused and wasn't paired for a ninth-round game, the federation said at the time. The organization noted that another grandmaster, Ian Nepomniachtchi, was fined earlier in the day for wearing sports shoes, changed and continued to play. Carlsen has said that he offered to wear something else the next day, but officials were unyielding. He said “it became a bit of a matter of principle,” so he quit the rapid and blitz championships. In the video posted Sunday, he questioned whether he had indeed broken a rule and said changing clothes would have needlessly interrupted his concentration between games. He called the punishment “unbelievably harsh.” “Of course, I could have changed. Obviously, I didn’t want to,” he said, and “I stand by that.”
Elon Musk attacks Australian government over proposed social media banIs Outlook down? Thousands of Microsoft 365 users report outage issuesAdewale 0-2 0-0 0, Klaczek 0-5 4-4 4, Briggs 4-9 6-6 17, Marshall 3-7 9-10 17, Strand 1-4 2-2 5, Neely 6-14 0-0 12, Matulu 1-1 0-0 2, Lindsey 4-5 0-0 8, Taylor 1-4 0-0 3, Adnan 0-2 0-0 0, Reddish 0-1 0-0 0, Topuz 0-2 0-0 0, Giralt 0-0 0-2 0. Totals 20-56 21-24 68. Fielder 3-6 3-3 10, Sorber 6-9 1-1 14, Epps 4-7 0-0 8, Mack 6-8 1-1 16, Peavy 9-14 3-3 24, Burks 5-6 0-0 11, Mulready 1-3 0-0 2, Ca.Williams 4-6 1-1 9, Cu.Williams 2-3 0-0 4, McKenna 1-1 0-0 2, Montgomery 0-1 0-0 0, Asadallah 0-1 0-0 0. Totals 41-65 9-9 100. Halftime_Georgetown 49-35. 3-Point Goals_Albany (NY) 7-22 (Briggs 3-5, Marshall 2-3, Strand 1-3, Taylor 1-3, Adnan 0-1, Reddish 0-1, Topuz 0-1, Klaczek 0-2, Neely 0-3), Georgetown 9-22 (Mack 3-4, Peavy 3-6, Burks 1-2, Fielder 1-2, Sorber 1-2, Montgomery 0-1, Cu.Williams 0-1, Epps 0-2, Mulready 0-2). Rebounds_Albany (NY) 21 (Neely 5), Georgetown 33 (Sorber 13). Assists_Albany (NY) 6 (Marshall, Neely 2), Georgetown 26 (Peavy 8). Total Fouls_Albany (NY) 14, Georgetown 17.
Summit Therapeutics Inc. ( NASDAQ:SMMT – Get Free Report ) dropped 6.2% during trading on Friday . The stock traded as low as $17.98 and last traded at $18.09. Approximately 882,894 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 3,409,062 shares. The stock had previously closed at $19.28. Analyst Ratings Changes Several equities research analysts recently weighed in on the stock. Stifel Nicolaus upped their target price on shares of Summit Therapeutics from $25.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. JMP Securities assumed coverage on Summit Therapeutics in a research report on Monday, November 4th. They set a “market outperform” rating and a $32.00 price objective on the stock. Citigroup lowered Summit Therapeutics from a “buy” rating to a “neutral” rating and lifted their target price for the company from $19.00 to $23.00 in a report on Friday, September 27th. HC Wainwright reissued a “buy” rating and set a $44.00 target price on shares of Summit Therapeutics in a research note on Monday, November 18th. Finally, Wells Fargo & Company began coverage on Summit Therapeutics in a research report on Wednesday, December 11th. They issued an “overweight” rating and a $30.00 price target on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $33.33. Read Our Latest Research Report on Summit Therapeutics Summit Therapeutics Price Performance Institutional Investors Weigh In On Summit Therapeutics Several institutional investors have recently added to or reduced their stakes in SMMT. Principal Financial Group Inc. raised its holdings in Summit Therapeutics by 60.9% during the third quarter. Principal Financial Group Inc. now owns 58,147 shares of the company’s stock worth $1,273,000 after purchasing an additional 22,014 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of Summit Therapeutics in the 3rd quarter valued at $2,091,000. Virtu Financial LLC acquired a new stake in Summit Therapeutics during the 3rd quarter worth $925,000. Geode Capital Management LLC lifted its position in Summit Therapeutics by 4.6% in the third quarter. Geode Capital Management LLC now owns 3,099,808 shares of the company’s stock valued at $67,899,000 after acquiring an additional 135,981 shares during the last quarter. Finally, XTX Topco Ltd boosted its stake in Summit Therapeutics by 54.3% in the third quarter. XTX Topco Ltd now owns 23,915 shares of the company’s stock valued at $524,000 after acquiring an additional 8,415 shares in the last quarter. Hedge funds and other institutional investors own 4.61% of the company’s stock. About Summit Therapeutics ( Get Free Report ) Summit Therapeutics Inc, a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company’s lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. Recommended Stories Receive News & Ratings for Summit Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .Woodland Farm Brewery celebrates 9 years of brewing in Marcy